Cogent Biosciences Inc
(COGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 64,387 | 62,404 | 58,228 | 59,580 | 47,085 |
| Operating Income | -64,387 | -62,404 | -58,228 | -59,580 | -47,085 |
| Other Income | 5,437 | 4,056 | 3,863 | 4,198 | 3,009 |
| Pre-tax Income | -58,950 | -58,348 | -54,365 | -55,382 | -44,076 |
| Net Income Continuous | -58,950 | -58,348 | -54,365 | -55,382 | -44,076 |
| Net Income | $-58,950 | $-58,348 | $-54,365 | $-55,382 | $-44,076 |
| EPS Basic Total Ops | -0.43 | -0.49 | -0.16 | -0.64 | -0.59 |
| EPS Basic Continuous Ops | -0.59 | -0.62 | -0.64 | -0.64 | -0.59 |
| EPS Diluted Total Ops | -0.43 | -0.49 | -0.16 | -0.64 | -0.59 |
| EPS Diluted Continuous Ops | -0.59 | -0.62 | -0.64 | -0.64 | -0.59 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -0.62 | -0.63 | N/A | N/A |
| EBITDA(a) | $-61,200 | $-63,201 | $-61,932 | $-58,090 | $-47,260 |